Default company panoramic image
068bdda6 4a78 48b6 9078 ad7e78bdc884

PLC Diagnostics

Detecting Multiple Bio-markers in a Single Drop of Blood in 5 minutes at the Point of Care

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Los Angeles, CA, USA
  • Currency USD
  • Founded March 2007
  • Employees 5
  • Incorporation Type Not Incorporated
  • Website plcds.com

Company Summary

PLC Diagnostics Inc. has developed a revolutionary detection technology, Q-SENS, capable of detecting multiple bio-markers in a single, finger prick, drop of blood. This next generation handheld device and its disposable cartridge are based on a proprietary waveguide technology offering central-lab quality testing at the point of care. The platform offers multiplexing (up to 100), unparalleled sensitivity and short (5 min) turnaround time.

Team

  • Default avatar
    Reuven Duer
    Founder & CSO

    Dr. Duer is an expert in optical waveguide technology, has been awarded multiple patents and developed several products using the technology is a variety of different fields. Dr. Duer has over 18 years of experience in the high-tech start-up industry leading multidisciplinary development teams.
    Dr. Duer received his Ph.D. in Physics from the Technion—Israel Institute of Technology and his Master’s degree from Weizmann Institute of Science.

  • Default avatar
    Henry L. Nordhoff
    Chairman of the Board

    Gen-Probe (Chairman & CEO); Chugai Biopharmaceuticals (CEO); TargeTech (CEO); American Biogenetic Sciences (CEO); Pfizer.
    Mr. Nordhoff has served as a director of Gen-Probe since July 1994. Mr. Nordhoff joined Gen Probe in July 1994 as Chief Executive Officer and President and was elected Chairman of the Board in September 2002. Mr. Nordhoff retired as the Company's Chief Executive Officer on May 17, 2009.

  • Default avatar
    John Glancy
    Interim COO

    John Glancy, Interim COO - Over 15 years experience in semiconductor operations, including roles as fabrication plant manager at Intel and managing semiconductor foundries while leading fabless operations at several startups. MS in Mechanical Engineering and MS in Management from MIT’s Leaders for Global Operations Program.

  • Default avatar
    Abraham D. Sofaer
    co-founder & Board Member

    Abraham D. Sofaer Cofounder & General Counselor - Retired federal judge; national security scholar and arbitrator; experienced investor in bio-tech; former member of the Gen-Probe and other commercial and charitable boards.

  • Default avatar
    James N. Herron
    Co-founder & chairman of scientific advisory board

    James N. Herron. Ph.D. Cofounder & Scientific Advisory Board Chairman - Professor of Pharmaceutical Chemistry and Bioengineering, University of Utah.

  • Default avatar
    Anthony DiMaria
    Consultant & advisory board member

    Dr. Anthony Demaria, Advisory Board Member – Editor in Chief of the Journal of American College of Cardiology (JACC). Founding director and Chair of Cardiology of the Sulpizio Cardiovascular Center at UCSD.

  • Default avatar
    Paul E. Gargan
    Interim CEO

    Paul E. Gargan, Ph.D. Chairman of Strategy Advisory Board and Interim CEO - Gen-Probe (SVP Bus Dev), 25 years of experience in clinical diagnostic industry; 15 years as leader in various business functions at Gen-Probe ; American Biogenetic Sciences (President & COO); Roka Biosciences; Qualigen Inc (Board member) MBA from The University of Notre Dame.

Advisors

  • Default avatar
    Latham & Watkins
    Lawyer
    Unconfirmed
    Default avatar
    Gehirardo CPA
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    Angle investors (North Bay Angles)
    Unconfirmed
    Default avatar
    Family & friends
    Unconfirmed